Welcome to LookChem.com Sign In|Join Free

CAS

  • or

133116-84-4

133116-84-4

Post Buying Request

133116-84-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

133116-84-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 133116-84-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,1,1 and 6 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 133116-84:
(8*1)+(7*3)+(6*3)+(5*1)+(4*1)+(3*6)+(2*8)+(1*4)=94
94 % 10 = 4
So 133116-84-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H7F3N4/c10-9(11,12)4-2-1-3-5-6(4)7(13)16-8(14)15-5/h1-3H,(H4,13,14,15,16)

133116-84-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(Trifluoromethyl)-2,4-quinazolinediamine

1.2 Other means of identification

Product number -
Other names 3-pyridinecarboxylic acid,4,6-diamino

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:133116-84-4 SDS

133116-84-4Relevant articles and documents

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND QUINAZOLINE DERIVATIVES

-

Page/Page column 121, (2021/01/22)

Therapeutic combinations of hepatitis B virus (HBV) vaccines and quinazoline derivatives are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed therapeutic combinations are also described. The invention provides therapeutic combinations or compositions and methods for inducing an immune response against hepatitis B viruses (HBV) infection.

Synthesis of 5-trifluoromethyl-5,8-dideazafolic acid and 5-trifluoromethyl-5,8-dideazaisofolic acid

Singh,Govindan,Hynes

, p. 2101 - 2105 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 133116-84-4